AnalystsLisa WalterLisa Walter's Stock Forecasts
AnalystsLisa Walter
Sectors:
Industries:
Analyst Ranking
Bottom 12%
#4693 out of 5279 analysts
Average Return
-3.62%
Win Rate
30%7 out of 23
Risk vs Reward
Poor
Good
Lisa Walter's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Eyepoint IncEYPT | +32.80% | $8.81 | $11.70 | 2025-06-16 - 2026-05-18 | Buy |
United Therapeutics CorpUTHR | +31.05% | $432.66 | $566.99 | 2025-09-25 - 2026-05-18 | Buy |
United Therapeutics CorpUTHR | +25.02% | $453.53 | $566.99 | 2025-10-29 - 2026-05-18 | Buy |
Viridian Therapeutics IncVRDN | +15.33% | $13.96 | $16.10 | 2026-04-06 - 2026-05-18 | Buy |
Meiragtx Holdings PLCMGTX | +14.77% | $8.19 | $9.40 | 2025-11-13 - 2026-05-18 | Buy |
Lisa Walter Analyst Color
Get additional color on Lisa Walter's coverage of popular stocks
Lisa Walter's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Meiragtx Holdings PLCMGTX | 3 | Buy | $25.00 | +165.96% | Maintains | 4 days ago |
United Therapeutics CorpUTHR | 4 | Buy | $701.00 | +23.64% | Maintains | 12 days ago |
Mirum Pharmaceuticals IncMIRM | 1 | Buy | $142.00 | +48.71% | Maintains | 12 days ago |
Eyepoint IncEYPT | 3 | Buy | $37.00 | +216.24% | Maintains | 12 days ago |
Viridian Therapeutics IncVRDN | 5 | Buy | $34.00 | +111.18% | Maintains | 13 days ago |
Rhythm Pharmaceuticals IncRYTM | 3 | Buy | $137.00 | +57.76% | Maintains | 13 days ago |
Ocular Therapeutix IncOCUL | 1 | Buy | $30.00 | +258.00% | Reiterates | 13 days ago |
4d Molecular Therapeutics IncFDMT | 3 | Buy | $35.00 | +318.41% | Maintains | 2 months ago |
Apellis Pharmaceuticals IncAPLS | 2 | Hold | $21.00 | -48.82% | Maintains | 3 months ago |
Adverum Biotechnologies IncADVM | 1 | Hold | $4.00 | -8.26% | Maintains | 7 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.